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Abstract
Background: Although depression and anxiety disorders are very common in people with epilepsy; there are no
studies that assessed the magnitude and associated factors among epileptic people in Ethiopia. Therefore, this
study determined prevalence and associated factors of depression and anxiety disorders in people with epilepsy.
Method: An institution based cross-sectional study was conducted from April to May, 2013, among 423 people
with epilepsy from the outpatient department of Amanuel Mental Specialized Hospital. Depression and anxiety
were assessed using the Hospital Anxiety and Depression Scale. Logistic regression analysis was used to assess
predictors of depression and anxiety.
Results: The prevalence of anxiety and depression among epileptic people were 33.5 and 32.8 %, respectively.
Monthly income, frequency of seizure and side effects of anti convulsants were found to be significantly associated
with both depression and anxiety. Being divorced/widowed was associated with anxiety while using poly-therapy
of anti convulsants, perceived stigma, and inability to read or write were associated with depression.
Conclusion: The prevalence of co-morbid anxiety and depression was found to be high among people with
epilepsy. Early identification of co-morbid depression and anxiety in people with epilepsy and managing epilepsy
to become seizure free should be of great concern for health care providers.
Background
Epilepsy is a common neurological condition character-
ized by recurrent and unpredictable seizures associated
with significant psychological and social consequences.
More than eighty percent of 50 million people living
with epilepsy (PWE) worldwide reside in low-income re-
gions where human and technological resources for
health care are extremely limited. Although epilepsy is
more likely to be diagnosed in childhood or elder years,
it is not confined to any age group, sex or race. Frequent
seizures may cause difficulties in important areas of life (at
school or the workplace), as well as sometimes hindering
the development of new friendships and relationships.
Fortunately, epilepsy can be managed with antiepileptic
medications and more than 70 percent of people become
seizure-free with treatment [1–3].
Depression is characterized by loss of interest, de-
pressed mood, disturbance of sleep, problem in appetite
and psychomotor activity, difficulty to concentrate or
make decision, guilty or sinful feeling, easily tiredness
and recurring thoughts of death or suicide [4]. Anxiety
is the presence of fear or apprehension that is out of
proportion to the context of the life situation. An anx-
iety disorder can be expressed in different ways such as
uncontrollable worry, intense fear (phobias or panic at-
tacks) or upsetting dreams or flashbacks of a traumatic
event [4, 5].
Depression and anxiety disorders are very common in
people with epilepsy. The altered brain activity that causes
epileptic seizures can lead to depressive moods and the
stress of living with a chronic condition can worsen feel-
ings of depression and anxiety. As a consequence, epilepsy
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may be more difficult to manage as depression is some-
times known to make seizures more frequent and can de-
crease the motivation to manage epilepsy effectively [6].
People with epilepsy experience depression at two to
three times the rate of the general population [7]. Litera-
tures reported a strong link between epilepsy, depression
and anxiety disorders. The disorders can be aggravated or
developed following being diagnosed for epilepsy; or as a
consequence of living with epilepsy. Structural brain abnor-
malities, monoamine pathways, cerebral glucose metabol-
ism and the hypothalamic-pituitary-adrenal axis are also
associated with the pathogenesis of depression in people
with epilepsy. But once they are diagnosed, depression and
anxiety disorders can be safely and effectively treated at the
same time as epilepsy. Treatments for mental health condi-
tions can greatly improve quality of life and can reduce the
frequency and impact of seizures [8, 9].
According to different world wide literatures the
magnitude of depression and anxiety disorder among
adult epileptic people had a varied figure. The presence
of depressive symptoms accounted 20 % in Thailand
[10], 25 % in India [11], 24 to 32 % in Brazil [12, 13],
38 and 60 % at China and Pakistan, respectively [14,
15]; where as it was 25.5 % in Egypt [16]. In addition,
anxiety disorders were reported among 39 % of
Thailand subjects [10], 33 to 39 % of Brazilian partici-
pants [12, 13], 30 % of Chinese [14] and 47 % of
Egyptians [16].
There are multiple risk factors associated with in-
creased risk of psychiatric problems in epilepsy which
can be broadly divided into biological (e.g. type and se-
verity of epilepsy), psychosocial and iatrogenic (antiepi-
leptic drugs, surgery) [17].
On the other hand, different factors were reported as
significant factors for co-existence of depression and
anxiety disorder among epileptic people. Female gen-
der, frequent seizures, perceived stigma, low schooling,
suicidal thought, or attempt, poly therapy and poor
seizure control were risk factors for anxiety disorders
[10, 12, 13, 16]. Similarly, having frequent seizure, head
trauma, perceived stigma, lower educational level, sui-
cidality [12, 13], male gender, being married, low socio
economic status, uncontrolled seizure and poly therapy
were significantly associated with depression [15].
There are limited studies which showed the magni-
tude of depression and anxiety among epileptic pa-
tients in Sub-Saharan region particularly in Ethiopia.
The aim of this study was to determine the magni-
tude of depression and anxiety disorders among epi-
leptic people at Amanuel Mental Specialized Hospital,
Ethiopia. Hence, the findings might have importance
to stakeholders and policy makers working in Neuro-
Psychiatric areas by showing its prevalence and the
factors associated with it.
Methods
Study settings and population
A cross sectional study design was conducted at Amanuel
Mental Specialized Hospital (AMSH) in Addis Ababa
from April to May, 2013. AMSH is one of oldest hospitals
established in 1937 and located in western part of Addis
Ababa, the capital city of Ethiopia. Ethiopia is the second-
most populous country in Sub-Saharan Africa with a
population of more than 85 million people. It is an agrar-
ian country and agriculture accounts for 43 percent of the
gross domestic product. Primary health service coverage
has reached 93 % with 127 hospitals, 3,245 health centers,
16,048 health posts and more than 4,000 private for profit
and not for profit clinics [18]. In Ethiopia, epilepsy is often
mistakenly seen as a form of mental illness by the com-
munity and is usually treated by psychiatrists and psychi-
atric nurses. The most prescribed antiepileptic drugs were
phenobarbitone, phenytoin and sometimes carbamazepine
and sodium valproate. The hospital gives service for ap-
proximately 1200 epileptic patients per month.
The Study population was epileptic patients who had
treatment follow up at outpatient department during
study period. Patients aged 18 years and above with
diagnosis of epilepsy and under treatment with one or
more antiepileptic drugs from the outpatient units for at
least 6 months were included in the study. Patients with
serious general medical condition and unable to com-
municate were excluded.
Sample size and sampling procedures
The sample size for the study was calculated using the
formula [n = ((zα/2)2 p (1-p))/ d2] for estimating a single
population proportion at 95 % confidence interval (CI)
(Zα/2 = 1.96), 5 % margin of error. Due to absence of
data in the country; proportion of population living with
epilepsy and who had depression and anxiety was as-
sumed to be 50 %, and by adding 10 % contingency for
non response rate, a total of 423 study populations were
involved.
Systematic sampling method was used to select
study population coming to AMSH during the study
period from 1200 epileptic people. AMSH has 13 out-
patient departments from which two of them are
neurologic clinics. Sampling interval was determined
by dividing total study population who had follow up
during one month data collection period (1200) by
total sample size (423).The sampling fraction is: 1200/
423 ≈ 3. The first individual was selected by lottery
method, and the next respondent was chosen at regu-
lar intervals (every 3rd) by data collectors.
Data collection and quality control
The data was collected using a pretested structured
questionnaire developed in English and translated to
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Amharic and then to English by expertise and senior
psychiatrist to ensure its consistency. The questionnaire
was pre-tested on 5 % of the sample size at AMSH two
days prior to data collection. The questionnaire included
socio-demographic characteristics and clinical factors of
epilepsy. Concerning co-morbid anxiety, depression and
stigma, Hospital Anxiety and Depression Scale (HADS)
and stigma scale were used, respectively. HADS is a 14-
item questionnaire, commonly used to screen for symp-
toms of anxiety and depression. The 14-items can be
separated into two 7-item sub-scales for anxiety and de-
pression. HADS scale was validated in Ethiopia and the
internal consistency was 0.78 for the anxiety, 0.76 for de-
pression subscales and 0.87 for the full scale. The scales
use a cut -off score for anxiety and depression of greater
than or equal to 8 [19]. Felt stigma was assessed by
three-item stigma scale which is validated at Zambia and
comprised of dichotomous questions in which a positive
response is indicative of felt or perceived stigma with an
overall possible score ranging from 0 (no felt stigma) to
3 (maximally felt stigma) [20]. Data was collected by
three trained diploma psychiatry nurses and one super-
visor (BSc nurse) for a period of one month. Face to face
interview was employed using local Amharic language.
Two days training was given to orient data collectors
and supervisor on the questionnaire to be used, the
purpose of the study and how to approach respondents
and obtain consent. The data collectors were supervised
daily and the filled questionnaires were checked for
completeness and consistency by supervisor and princi-
pal investigator.
Data management and analysis
The data was coded, checked, cleaned and entered into
computers using software Epi Info version 3.5.4 and then
exported into SPSS window version 20 for analysis. Fre-
quency, percentage, median were used to describe relevant
variables using tables and graphs. Logistic regression was
performed to assess the association between binary out-
comes and different explanatory variables. Bivariate ana-
lysis was first conducted for each potentially explanatory
risk factor. Variables that satisfied p-value < 0.2 were
selected for further analysis using multivariate logistic re-
gression analysis in order to control confounding effects.
The strength of association was interpreted using odds
ratio (OR) and confidence interval (CI). P-value < 0.05
was considered statistically significant in this study.
Ethical consideration
Ethical clearance was obtained from University of Gondar
and AMSH. Informed consent was obtained from the re-
spondents. They were given the right to refuse to take part
in the study as well as to withdraw at any time during the
interview process. Confidentiality was maintained through-
out the study.
Results
Socio-demographic characteristics of the respondents
Of the total 423 study participants enrolled, 415 were inter-
viewed yielding a response rate of 98 %. Respondents’ age
ranged from 18 to 72 years with a median age of 28 years.
Around fifty five percent of the respondents were males. Of
the total respondents, 42.7 % were in the age group of 25–
34 years. Majority of the respondents were single (61.4 %),
urban dwellers (84.6 %), orthodox followers (67.0 %), having
job (78.1 %), and Amhara (38.1 %) followed by Oromo
(29.2 %) by ethnicity. Regarding educational status, 37.6 %
attended secondary school followed by primary school
(36.4 %) (Table 1).
Clinical characteristics of the respondents
Out of the total 415 respondents, 35.2 % were with epi-
lepsy for five years followed by eleven years and above
(34.2 %). Concerning age at onset of illness, 38.8 %
found between 10–19 years and 20–29 years (35.4 %).
Most of the respondents (54.9 %) had one or more seiz-
ure attacks per month, under monotherapy (single anti-
epileptic drug) (61.9 %) and had no side effects of
antiepileptic drugs (52.5 %). Around forty percent of the
respondents perceived that they were stigmatized by
other people because of their illness (Table 2).
Prevalence of depression and anxiety among epileptic
patients
The prevalence of anxiety symptoms among epileptic
patient was found to be 33.5 % whereas prevalence of
depression was 32.8 % (Fig. 1).
Factors associated with co-morbid anxiety and depression
On bivariate analysis, the factors found to fulfill the mini-
mum requirement (p-value < 0.2 in this study) were age,
marital status, educational level, occupation, monthly in-
come, frequency of seizure, types of drugs, side effects of
antiepileptic drugs (AEDs) and perceived stigma. However,
no significant association was noted in depression and anx-
iety between males and females among epilepsy patients.
Moreover, no differences were found among study variables
like residence, duration of illness, both ever and current use
of psychoactive substance at minimum requirement.
The results of multivariate logistic regression showed
that monthly income, frequency of seizure and side
effects of AEDs were significantly associated with both
depression and anxiety. However, being divorced/
widowed was significantly associated with anxiety where
as perceived stigma, types of AEDs, and unable to read
and write were associated with depression.
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It was found that lower educational level was signifi-
cantly associated with depression. Being unable to read
and write was four times (AOR = 4.36, 95 % CI: 1.33,
14.21) more likely to have depression as compared to re-
spondents with educational level of diploma and above.
The result indicated that patients who had low income
were about four and three times more likely to have
depression and anxiety, respectively as compared to pa-
tients who had high income (AOR = 4.14, 95 % CI: 1.67,
10.25 and AOR = 3.01, 95 % CI: 1.52, 5.96).
Frequency of seizure was another factor associated
with both depression and anxiety. Those who had seiz-
ure frequency greater than or equal to one seizure/
month were three times and twice more likely to have
depression and anxiety as compared to patients with no
seizure in one year period, respectively (AOR = 3.55,
95 % CI: 1.82, 6.93 and AOR = 2.21, 95 % CI: 1.28, 3.79).
Moreover, patients who perceived stigma were twice
more likely to have depression as compared to patients
who didn’t perceived stigma (AOR = 1.77, 95 % CI: 1.07,
2.93). Similarly, patients who were taking two or more
types of AEDs were twice more likely to have depression
as compared to patients who were taking one type of
AEDs (AOR = 1.85, 95 % CI: 1.08, 3.17). Regarding
side effects of medication, those who had side effects
of AEDs were around three times more likely to have
co-morbid anxiety and depression (AOR = 2.51, 95 % CI:
1.60,3.94) and AOR= 3.07, 95 % CI: 1.80,5.21, respectively)
(Tables 3 and 4).
Discussion
In this study, the prevalence of anxiety among epileptic
people was 33.5 % and the prevalence of depression was
32.8 %. The prevalence of anxiety was in line with the
study done in China (30 %) and Brazil (33-39 %) [12, 14].
Table 1 Distribution of respondents by socio-demographic
characteristics at AMSH, Addis Ababa, 2013 (n = 415)
Variable Number Percentage (%)
Sex Male 229 55.2
Female 186 44.8




Marital status Single 255 61.4
Married 146 35.2
Divorced/Widowed 14 3.4
Residence Urban 351 84.6
Rural 64 15.4
Religion Orthodox 278 67.0
Muslim 84 20.2
Protestant 47 11.3
All others 6 1.4





Educational status Unable to write and read 35 8.4
Primary school 151 36.4
Secondary school 156 37.6
Diploma and above 73 17.6
Occupation With Job 324 78.1







Table 2 Distribution of respondents by clinical factors at AMSH,
Addis Ababa, 2013 (n = 415)
Variable name Frequency Percent
Duration of illness ≤5 years 146 35.2
6-10years 127 30.6
≥11 years 142 34.2
Age at onset of illness <10 years 53 12.8
10-19 years 161 38.8
20-29 years 147 35.4
≥30 years 54 13.0





Type of drugs One 257 61.9
≥two 158 38.1




Medication duration ≤5 years 232 55.9
6-10 years 79 19.0
≥11 years 104 25.1
Perceived stigma Yes 169 40.7
No 246 59.3
Ever use substance Yes 53 12.8
No 362 87.2
current use substance Yes 29 7.0
No 386 93.0
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However, in the present study, it was lower than the result
reported from Thailand (39 %) and Egypt (47 %) [10, 16].
The possible reason for the difference might be the inclu-
sion criteria in Thailand were age between 15–50 years
and could read and fill with self-administered question-
naire, while in Egypt there was instrument difference
which is beck depression inventory and HAM-A and
exclude any substance use, neurologic disease other than
epilepsy.
The prevalence of depression (32.8 %) among epileptic
people, in this study, is higher than the result (20 %) re-
ported from Thailand [10] and lower than the result
(60 %) in Pakistan [15]. Methodological issues might
have contribution for differences found, for example, in
Fig. 1 Frequency of depression and anxiety symptoms among epileptic people attending at AMSH, 2013
Table 3 Bivariate and multivariate analysis of variables associated with anxiety among epileptic patients at AMSH, Addis Ababa
Ethiopia, 2013 (n = 415)
Variable Anxiety
Yes No COR(95 % CI) AOR(95 % CI)
Marital status Married 41 105 1 1
Single 88 167 1.39(0.86,2.10) 1.22(0.75,1.96)
Divorced/widowed 10 4 6.40(1.90,21.56) 6.27(1.69,23.16)**
Education Unable to read &write 19 16 2.58(1.12,5.91)* 1.08(0.38,3.06)
primary school 47 104 0.98(0.53,1.79)* 0.54(0.25,1.16)
Secondary school 50 106 1.02(0.56,1.86) 0.65(0.32,1.33)
Diploma &above 23 50 1 1
Occupation With Job 97 227 1 1
Without Job 42 49 2.00(1.24,3.22)* 1.14(0.61,2.14)
Monthly income <200 55 62 3.82(1.98,7.35)* 3.01(1.52,5.96)**
200-500 42 68 2.66(1.36,5.18)* 2.24(1.11,4.49)**
501-1000 26 77 1.45(0.72,2.93)* 1.44(0.68,3.04)
>1000 16 69 1 1
Frequency of attack ≥1/month 96 132 2.88(1.74,4.77)* 2.21(1.28,3.79)**
1-3/year 17 41 1.64(0.80,3.34)* 1.41(0.67,2.99)
Seizure free/year 26 103 1 1
Type of drugs One 66 191 1 1
≥ two 73 85 2.48(1.63,3.78)* 1.49(0.91,2.46)
Side effects of AED Yes 92 105 3.18(2.07,4.88)* 2.51(1.60,3.94)**
No 47 171 1 1
Perceived stigma Yes 75 94 2.26(1.49,3.44)* 1.38(0.86,2.20)
No 64 182 1 1
Note: *P < 0.2 **P < 0.05
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Thailand; only those who could read and communicate
were included. Education is one of the associated factors
of depression as indicated in our study which is also in
line with study done in Jimma [19]. Furthermore, the
difference in sampling procedures and diagnostic instru-
ment for depression and anxiety (different scales) might
have a role for the variation.
Different studies indicated that people with low eco-
nomic status and participants in low educational level
had a higher risk of depression and anxiety [21–23]. The
results of these studies are consistent with our study.
Regarding clinical factors, side effects of AEDs and fre-
quency of seizure were associated with co-morbid depres-
sion and anxiety in this study. People who had side effects
of medication and frequent seizure were found to have de-
pression and anxiety as compared to people who had no
side effects of medication and no seizure. This finding was
consistent with many previous studies [9, 24].
The results of the present study also revealed that de-
pression is significantly influenced by felt stigmatization
about their epilepsy; which is in line with study done in
Mangalore city of south India [25].
The strength of this study is the first of its kind in
Ethiopia that determined the prevalence and associated
factors for both depression and anxiety among epileptic
patients. However, our limitations include recall bias re-
garding duration of illness, age at the onset of seizure
and medication duration. Some important variables such
as intellectual disability and treatment adherence were
not assessed.
Conclusion
The prevalence of co-morbid anxiety and depression was
found to be high among epileptic people in this study. Un-
able to read and write, low monthly income, frequent at-
tacks of seizure, treatment with two or more drugs, side
effects of AEDs and perceived stigma were significantly as-
sociated with co-morbid anxiety and depression. Clinicians
and neurologists should early identify co-morbid psychi-
atric illnesses like depression and anxiety in people with
Table 4 Bivariate and Multivariate analysis of variables associated with depression among epileptic people at AMSH, Addis Ababa
Ethiopia, 2013 (n = 415)
Variable Depression
Yes No COR(95 % CI) AOR(95 % CI)
Age 18-24 30 100 0.79(0.35,1.76) 0.75(0.25,2.17)
25-34 66 111 1.56(0.73,3.34) 2.29(0.83,6.31)
35-44 29 39 1.96(0.84,4.56) 2.29(0.76,6.87)
45+ 11 29 1 1
Education Unable to read &write 21 14 6.92(2.80,17.09)* 4.36(1.33,14.21)**
primary school 48 103 2.15(1.07,4.29)* 1.44(0.61,3.40)
Secondary school 54 102 2.44(1.23,4.84) 2.52(0.90,5.81)
Diploma &above 13 60 1 1
Occupation With Job 93 231 1 1
Without Job 43 48 2.22(1.38,3.58)* 1.25(0.62,2.54)
Monthly income <200 52 65 5.38(2.59,11.17)* 4.14(1.67,10.25)**
200-500 44 66 4.48(2.14,9.39)* 4.17(1.69,10.24)**
501-1000 29 74 2.63(1.22,5.66)* 3.34(1.37,8.10)**
>1000 11 74 1 1
Frequency of attack ≥1/month 104 124 5.92(3.30,10.63)* 3.55(1.82,6.93)**
1-3/year 16 42 2.69(1.23,5.85)* 1.83(0.76,4.41)
Seizure free/year 16 113 1 1
Type of drugs One 57 200 1 1
≥ two 79 79 3.50(2.28,5.38)* 1.85(1.08,3.17)**
Side effects of AED Yes 97 100 4.45(2.85,6.94)* 3.07(1.80,5.21)**
No 39 179 1 1
Perceived stigma Yes 78 91 2.77(1.82,4.23)* 1.77(1.07,2.93)**
No 58 188 1 1
Note: *P < 0.2 **P < 0.05
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epilepsy and it should be of great concern for health care
providers. Further research should be done in different part
of the country to provide stronger evidence regarding the
prevalence and factors associated with this co-morbid anx-
iety and depression among epileptic people.
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